M&A Looms on Med Tech Horizon
Canaccord Genuity analyst Jason Mills identifies five companies that, in his view, are most likely to be targeted for mergers and acquisitions over the next 12 months.
Canaccord Genuity analyst Jason Mills identifies five companies that, in his view, are most likely to be targeted for mergers and acquisitions over the next 12 months.